Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-02-13 @ 3:42 AM
Study NCT ID:
NCT00486668
Status:
UNKNOWN
Last Update Posted:
2016-06-06
First Post:
2007-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
2012-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03
Completion Date Type:
ESTIMATED
First Submit Date:
2007-06-13
First Submit QC Date:
None
Study First Post Date:
2007-06-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-03
Last Update Post Date:
2016-06-06
Last Update Post Date Type:
ESTIMATED